Kiniksa Pharmaceuticals International PLC reports results for the quarter ended June 30 - Earnings Summary

Kiniksa Pharmaceuticals International

29/07/2025 14:31

Kiniksa Pharmaceuticals International PLC KNSA.OQ reported quarterly adjusted earnings of 23 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -6 cents.  The mean expectation of six analysts for the quarter was for earnings of 18 cents per share. Wall Street expected results to range from 14 cents to 25 cents per share.

Revenue rose 51.7% to $156.80 million from a year ago; analysts expected $146.42 million.

Kiniksa Pharmaceuticals International PLC's reported EPS for the quarter was 23 cents​.

The company reported quarterly net income of $17.83 million.

Kiniksa Pharmaceuticals International PLC shares had fallen by 2.3% this quarter and gained 36.7% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 28.1% in the last three months.​

In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is  "buy."

Wall Street's median 12-month price target for Kiniksa Pharmaceuticals International PLC is $40.00, about 32.4% above its last closing price of $27.04

This summary was machine generated from LSEG data July 29 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
0.18
0.23
Beat
Mar. 31 2025
0.04
0.11
Beat
Dec. 31 2024
0.00
-0.12
Missed
Sep. 30 2024
0.03
-0.18
Missed